Strategies to avoid opiate withdrawal: Implications for HCV and HIV risks

International Journal of Drug Policy

Volumn 21, Issue 3, 2010, Pages 179-185

  Mateu Gelabert, Pedro ^a   Sandoval, Milagros ^a   Meylakhs, Peter ^b   Wendel, Travis ^a   Friedman, Samuel R ^a  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^b Center for Independent Social Research   (Russian Federation)

Author keywords

Hepatitis C and HIV prevention; Injection drug users; Opioid withdrawal

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COPING BEHAVIOR; GROUNDED THEORY; HEPATITIS C; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; INTERVIEW; LIFE HISTORY; OPIATE ADDICTION; PATIENT ATTITUDE; PRIORITY JOURNAL; UNITED STATES; WITHDRAWAL SYNDROME;

ADAPTATION, PSYCHOLOGICAL; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEPATITIS C; HEROIN; HIV INFECTIONS; HUMANS; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 77950458843     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2009.08.007     Document Type: Article

References (42)

1. Bourgois P. The moral economies of homeless heroin addicts: Confronting ethnography, HIV risk, and everyday violence in San Francisco Shooting Encampments. Substance Use & Misuse 1998, 33:2323-2351.
2. Booth D.J., Baker R. The impact of self-presentation and interviewer bias effects on self-reported heroin use. Addiction 1987, 82:8.
3. Brand S., Price R. The economic and social costs of crime 2000, Home Office, London.
4. Celentano D.D., Vlahov D., Cohn S., Anthony J.C., Solomon L., Nelson K.E. Risk factors for shooting gallery use and cessation among intravenous drug users. American Journal of Public Health 1991, 81:1291-1295.
5. Connors M.M. Risk perception, risk taking and risk management among intravenous drug users: Implications for AIDS prevention. Social Science & Medicine 1992, 34:591-601.
6. Connors M.M. Stories of pain and the problem of AIDS prevention: Injection drug withdrawal and its effect on risk behavior. Medical Anthropology Quarterly 1994, 8:47-68.
7. Craine N., Walker M., Carnwath T., Klee H. Hepatitis C testing and injecting risk behaviour: The results of a UK based pilot study. International Journal of Drug Policy 2004, 15:115-122.
8. Des Jarlais D.C., Perlis T., Arasteh K., Torian L., Hagan H., Beatrice S., et al. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001. AIDS 2005, 19:S20-S25.
9. Friedman S.R., Mateu-Gelabert P., Sandoval M., Hagan H., Des Jarlais D.C. Positive deviance control-case life history: A method to develop grounded hypotheses about successful long-term avoidance of infection. BMC Public Health 2008, 8:94.
10. Friedman, S. R., Sandoval, M., Mateu-Gelabert, P., Meylakhs, P., Des Jarlais, D.C. (in press). Symbiotic goals and the prevention of blood-borne viruses among injection drug users. Substance Use & Misuse.
11. Glaser B.G. Basics of grounded theory analysis: Emergence vs. forcing 1992, Sociology Press, Mill Valley, CA.
12. Godfrey C., Eaton G., McDougall C., Culyer A. The economic and social costs of Class A drug use in England and Wales 2000, Home Office, London.
13. Gordon D., Dahl J. Fast fact and concept #95. Opioid withdrawal 2007, End-of-Life/Palliative Education Resource Center, Retrieved October 1, 2008 from www.eperc.mcw.edu. 2nd ed.
14. Gossop M., Griffiths P., Powis B., Strang J. Severity of heroin dependence and HIV risk. II. Sharing injecting equipment. AIDS Care 1993, 5:159-168. http://www.informaworld.com/smpp/title~db=all~content=t713403300~tab=issueslist~branches=5%20-%20v52.
15. Grund J.P. Drug use as a social ritual: Functionality, symbolism and determinants of self-regulation 1993, Instituut voor Verslavingsonderzoek Hammersley, Rotterdam.
16. Grund J.P., Friedman S.R., Stern L.S., Jose B., Neaigus A., Curtis R., et al. Syringe-mediated drug sharing among injecting drug users: Patterns, social context and implications for transmission of blood-borne pathogens. Social Science & Medicine 1996, 42(5):691-703.
17. Grund J.P., Kaplan C.D., Adriaans N.F. Needle sharing in The Netherlands: An ethnographic analysis. American Journal of Public Health 1991, 81(12):1602-1607.
18. Hahn J.A., Page-Shafer K., Lum P.J., Bourgois P., Stein E., Evans J.L., et al. Hepatitis C virus seroconversion among young injection drug users: Relationships and risks. The Journal of Infectious Diseases 2002, 186:1558-1564.
19. Hagan H., Des Jarlais D.C. HIV and HCV infection among injecting drug users. The Mount Sinai Journal Of Medicine 2000, 67:5-6.
20. Hagan H., Des Jarlais D.C., Stern R., Lelitiu-Weinberger C., Scheinmann R., Strauss S. HCV synthesis project: Preliminary analyses of HCV prevalence in relation to age and duration of injection. International Journal of Drug Policy 2007, 18:341-351.
21. Hughes R.A. "When you're using gear you put HIV to the back of your mind and forget about it": Constructs of risk. Journal of Psychoactive Drugs 2004, 36:357-366.
22. Judd A., Hickman M., Jones S., McDonald T., Parry J., Stimson G. Incidence of hepatitis C virus and HIV among new injecting drug users in London-Prospective cohort study. British Medical Journal 2005, 330:24-25.
23. Koester S., Booth R.E., Zhang Y. The prevalence of additional injection-related HIV risk behaviours among injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1996, 12:202-207.
24. Leshner, A. (2000). Oops: how casual drug use leads to addiction. U.S. Department of Health and Human Services, National Institutes of Health. Retrieved January 15, 2009 from http://www.nida.nih.gov/Published_Articles/Oops.html.
25. Maher L., Jiong L., Jalaludin B., Chant K., Kaldor J. High hepatitis C incidence in new injecting drug users: A policy failure?. Australian and New Zealand Journal of Public Health 2007, 31:30-35.
26. Mateu-Gelabert P., Maslow C., Flom P.L., Sandoval M., Bolyard M., Friedman S.R. Keeping it together: Stigma, response, and perception of risk in relationships between drug injectors and crack smokers, and other community residents. AIDS Care 2005, 17:802-813.
27. Mateu-Gelabert P., Treloar C., Agullo V., Sandoval M., Valderrama J.C., Maher L., et al. How can hepatitis C be prevented in the long-term?. International Journal of Drug Policy 2007, 18:338-340.
28. Page-Shafer K., Hahn J.A., Lum P.J. Preventing hepatitis C virus infection in injection drug users: Risk reduction is not enough. AIDS 2007, 21:1967-1969.
29. Plumridge E., Chetwynd J. The moral universe of injecting drug users in the era of AIDS: Sharing injecting equipment and the protection of moral standing. Aids Care 1998, 10(6):723-733.
30. Rhodes T., Treloar C. The social production of hepatitis C risk among injecting drug users: A qualitative synthesis. Addiction 2008, 103:1593-1603.
31. Ross M.W., Wodak A., Stowe A., Gold J. Explanations for sharing injection equipment in injecting drug users and barriers to safer drug use. Addiction 1994, 89:473-479.
32. Shewan D., Dalgarno P., Marshall A., Lowe E., Campbell M., Nicholson S., et al. Patterns of heroin use among a non-treatment sample in Glasgow (Scotland). Addiction Research 1998, 6(3):215-234.
33. Smolka M., Schmidt L.G. The influence of heroin dose and route of administration on the severity of the opiate withdrawal syndrome. Addiction 1999, 94:1191-1198.
34. Stein M.D., Dubyak P., Herman D., Anderson B.J. Perceived barriers to safe injection practices among drug injectors who remain HCV-negative. The American Journal of Drug and Alcohol Abuse 2007, 33:517-525.
35. Sternin J., Choo R. The power of positive deviance. Harvard Business Review 2000, 14-15.
36. Strang J., Griffiths P., Gossop M. Heroin smoking by 'chasing the dragon': Origins and history. Addiction 1997, 92:673-683.
37. Tyndall M.W., Currie S., Spittal P., Li K., Wood E., O'Shaughnessy M.V., et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS 2003, 17:887-893.
38. Volkow, N. (2008). Director's Message to Medical and Health Professionals. U.S. Department of Health and Human Services, National Institutes of Health. Retrieved January 15, 2009 from http://www.nida.nih.gov/about/welcome/medstaffmessage.html.
39. Warburton H., Turnbull P.J., Hough M. Occasional and controlled heroin use. Not a problem? 2005, Joseph Rowntree Foundation, York.
40. Wray J. Can we learn from successful mothers?. Journal of Tropical Pediatrics and Environmental Child Health 1972, 18:279.
41. Zeitlin M., Ghassemi H., Mansour M. Positive deviance in child nutrition-With emphasis on psychosocial and behavioral aspects and implications for development 1990, United Nations University Press, Tokyo.
42. Zinberg N. Drug, set and setting-The basis for controlled intoxicant use 1984, Yale University Press, New Haven and London.